Shares of German pharma major Bayer were up 4.6% at 30.45 euros after it released positive early trial results for its ...

Repair Biotechnologies has partnered with Genevant Sciences to combine its Cholesterol Degrading Platform (CDP) mRNA ...

Shionogi said today that it has submitted a New Drug Application (NDA) in Japan for zuranolone, a treatment in development ...

Lundbeck presented data from the TALISMAN study and AMULET trial of amlenetug for multiple system atrophy (MSA) at the ...

San Diego start-up 858 Therapeutics has raised $50 million in a Series B round led by Avidity Partners, with participation from new and existing investors. The funds will advance 858’s pipeline, ...